CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 10 enrolled
Drug / intervention
Hyperbaric Oxygen Treatment (HBOT)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00584480
NCT00584480Phase 3Completed
CompareCT.gov

Pilot Study of the Effect of Hyperbaric Oxygen Treatment on Behavioral and Biomarker Measures in Children With Autism

University of California, San Francisco·interventional·Posted Jan 2, 2008·Updated Aug 7, 2012

In Brief

A Phase 3 clinical trial evaluating Hyperbaric Oxygen Treatment (HBOT) for Autism. Completed, enrolled 10 participants.

Detailed Summary

The purpose of this study is to increase the understanding of the effect of Hyperbaric Oxygen Treatment (HBOT) on the behavior and functioning of children with autism. The main goal of this study is to demonstrate that HBOT is safe and tolerable in autistic children, and to measure the effect of HBOT on specific chemicals in their blood that may play a role in the child's behavior.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutism
Countries--
CollaboratorsUniversity of California, Davis

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 2, 2008
Enrollment StartOct 1, 2007
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 18.5 years ago

Interventions

Hyperbaric Oxygen Treatment (HBOT)other

1.5 ATA at 100% Oxygen of HBOT